DNA X INC (SONM)
NASDAQInformation TechnologyCommunication EquipmentSnapshot 2026-09-04
$3.24+0.62%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologyCommunication EquipmentSnapshot 2026-09-04
QuarterlyIQ Insights · SONM
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 23 industry peers · Company calendar date is not available
SONM — litigation filed
Dated 2026-08-13
Other Events. Based on the foregoing transactions, as of the date of the filing of this Current Report on Form 8-K/A, the Company believes it has stockholders’ equity in excess of the $2.5 million stockholders’ equity requirement for continued listing on The Nasdaq Capital Market pursuant to Listing Rule 5550(b)(1) (the “Equity Rule”), as reflected in the pro forma stockholders’ equity balance provided below. The Company is awaiting Nasdaq’s formal determination that it has evidenced complian…
Why it matters: Earnings results will provide insight into financial health and operational performance. This could affect stock price.
Watch forEarnings report shows revenue growth or better financial numbers.
Also watch forEarnings report shows ongoing losses or falling revenue.
Why it matters: Good capital management is important for funding growth and keeping cash flow. Clear updates can help investors.
Watch forThe company raised more than $4 million to help its operations.
Also watch forThe company reports a cash shortfall or cannot meet financial duties.
Why it matters: Compliance is key for keeping the company's public listing. A good decision can help investors.
Watch forNasdaq says DNA X has $2.5 million in stockholders’ equity.
Also watch forNasdaq confirms ongoing non-compliance. This could lead to delisting.
Why it matters: This cash is important for the DNA X trading business and liquidity.
Supportive ifAn announcement will confirm the $1.5 million cash payment by October 2026.
Worry ifNo news about the payment shows possible cash flow problems.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$362 on $10,000 · ±3.6% | How much price usually moves either way. |
| Bad day | $1,266 loss on $10,000 · 12.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,370 loss on $10,000 · 83.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: How the company uses cash from the asset sale will affect its growth in trading.
Supportive ifPublic statements will explain how the money supports the DNA X trading business.
Worry ifThere is no clear word on how the money will be used. This causes uncertainty.
Why it matters: Revenue growth from the AI trading platform is key to validating the business model. It will show if the transition is successful.
Supportive ifQ2 financial results report revenue from the DNA X trading platform.
Worry ifQ2 results show no revenue from the trading platform.
Why it matters: The launch is key for growth in revenue and market presence. It signals the start of the company's growth phase.
Supportive ifA public announcement confirms the launch of the new DNA X trading platform.
Worry ifNo announcement about the launch or major delays in the trading platform.
Why it matters: Compliance is key to keeping the company's listing. It affects investor trust.
Supportive ifNasdaq announced that it meets the $2.5 million equity rule.
Worry ifA notice from Nasdaq shows non-compliance with listing rules.
Why it matters: Revenue growth is essential to validate the strategic shift to AI and crypto trading.
Supportive ifQuarterly revenue from the DNA X trading platform exceeds $1 million.
Worry ifQuarterly revenue stays at zero or keeps going down.
Why it matters: Good capital management is needed to support operations and growth. It affects cash flow.
Watch forAnnouncement of a successful capital raise of more than $2 million.
Also watch forThere is news of higher debt or not getting needed capital.